Multiple myeloma trials in Serbia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Where

  Belgrade, Kamenitz, Kragujevac, Niš

  Age

  18 years and over

  People

  386 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT05645107 · EU 2022-502193-16-00
• Phase 1Taking people
  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  Where

  Belgrade, Kragujevac, Niš

  Age

  18 years and over

  People

  258 worldwide

  Run by

  Shanghai Henlius Biotech

  See details and how to joinNCT07477587
• Phase 1Taking people
  A Study in Leukemia Patients With Karonudib

  Where

  Belgrade, Kragujevac

  Age

  18 years to 75 years

  People

  50 worldwide

  Run by

  Thomas Helleday Foundation

  See details and how to joinNCT04077307
• No phaseTaking people
  European Myeloma Network (EMN) Sample Project

  Where

  Belgrade

  Age

  18 years and over

  People

  6,000 worldwide

  Run by

  European Myeloma Network B.V.

  See details and how to joinNCT06237803